Vinblastine Sulphate in the Treatment of Malignant Disease
1964

Vinblastine Sulphate in the Treatment of Malignant Disease

Sample size: 126 publication Evidence: moderate

Author Information

Author(s): N. M. Bleehen, A. M. Jelliffe

Primary Institution: The Middlesex Hospital, London

Hypothesis

Vinblastine sulphate is an effective treatment for advanced malignant disease.

Conclusion

Vinblastine is highly effective for managing various malignant lymphomas, particularly Hodgkin's disease, with minor side effects.

Supporting Evidence

  • Vinblastine showed a good response in Hodgkin's disease within 1-2 weeks of treatment.
  • 91 out of 116 patients treated with intermittent intravenous injection received adequate treatment for assessment.
  • Vinblastine is considered the most effective and least toxic agent for controlling systemic Hodgkin's disease.

Takeaway

Vinblastine is a medicine that helps treat certain types of cancer, especially one called Hodgkin's disease, and it usually doesn't cause many bad side effects.

Methodology

Patients received vinblastine primarily through intermittent intravenous injection, with varying dosages based on individual tolerance.

Limitations

The study primarily focuses on the use of vinblastine for lymphomas, and results for other cancer types were less promising.

Participant Demographics

Patients primarily had advanced malignant lymphomas, with some suffering from other types of cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication